The Paul Ehrlich Institute (German: Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, PEI) is a German federal agency, medical regulatory body and research ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Germany's Paul Ehrlich Institute (PEI) vaccine regulator said an evaluation of 20 antigen tests on the market showed no reduction in their ability to detect the COVID-19 Omicron variant over previous ...
Boehringer Ingelheim, a global leader in animal health, announces that the Paul Ehrlich Institute (PEI), as the competent authority of the Reference Member State (Germany) under the Mutual Recognition ...
Berlin/Langen – Bei den Anträgen auf klinische Prüfungen gab es im vergangenen Jahr im Vergleich zum Vorjahr einen leichten Zuwachs. Wie das Paul-Ehrlich-Institut (PEI) mitteilte, wurden 2024 809 ...
Langen. Da derzeit alle für die laufende Saison vorgesehenen trivalenten Efluelda-Impfstoffe als abverkauft gemeldet sind, hat das Paul-Ehrlich-Institut dem Zulassungsinhaber Sanofi in Ausnahme gemäß ...
The positions in the table below reflect the Paul-Ehrlich-Institut (PEI)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results